Explore the latest oncology biotech news, from clinical data to fundraising and biotech deals, in our September 2026 roundup.

Explore the preclinical research catching our eye in September 2026, from siRNA and in vivo CRISPR to targeted protein ...

At NLS Days 2026, life science companies and a record number of investors attended to showcase data, partner, and raise ...

Discover Andy Brown's long and arduous journey battling a type of non-Hodgkin lymphoma and how a clinical trial altered his ...

Take a look at the Eli Lilly pipeline in 2026 as the incretin franchise grows and fuels the rest of the company's pipeline.

Meet Spain's biotech ecosystem at BIOSPAIN 2026 in Bilbao. Now annual, the event draws 1,000+ companies and participants from 30+ countries.

Discover how early optimization in stable cell line development accelerates timelines and reduces downstream bottlenecks.

A lot is going on in the GLP-1 space in 2026, a market that landed $79 billion last year, and could shift significantly in the coming years.

Not a lot went down on the biotech deals front in August 2026, but it did see sustained collaboration in oncology and ...

When Vertex Pharmaceuticals announced early last year that its pain pill had received approval from the U.S. Food and Drug Administration (FDA), it marked a breakthrough in the hunt for new non-opioid ...

At the end of each year, Labiotech selects a list of biotech companies it believes are worth keeping an eye on for the coming year. In December 2023, we highlighted nine biotech companies as “ones to ...